Ets-1 Expression in Squamous Cells of the Oral Cavity
Ets-1 在口腔鳞状细胞中的表达
基本信息
- 批准号:7413995
- 负责人:
- 金额:$ 3.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-05-01 至 2009-04-30
- 项目状态:已结题
- 来源:
- 关键词:AnimalsApoptosisBehaviorBiochemicalBiological ModelsCell Cycle ProgressionCellsCoupledDefectDevelopmentDiagnostic Neoplasm StagingDown-RegulationEpithelialEpitheliumExhibitsExtracellular Matrix DegradationFibroblast Growth FactorGene ExpressionGene TargetingGenesGeneticGrowth Factor ReceptorsHumanInvasiveLeadLiverMalignant ConversionMalignant Squamous Cell NeoplasmMetalloproteasesModelingMolecularMouth NeoplasmsMusNeoplasm MetastasisNeoplasmsOncogenesOralOral cavityOvaryPathway interactionsPatientsPhenotypeProcessPropertyResearch DesignResearch PersonnelRoleSkin NeoplasmsSquamous CellSquamous EpitheliumStratified Squamous EpitheliumSurvival RateSystemTimeTransgenic AnimalsTransgenic MiceTransgenic OrganismsTumor AngiogenesisTumor Cell InvasionTumor Suppressor GenesTumor stageUp-RegulationUterusangiogenesisc-ets1 transcription factorcell growthinsightkeratinocytelymph nodesmalignant mouth neoplasmmouse modelmouth squamous cell carcinomaneoplasticneoplastic cellnovelnovel strategiesnovel therapeuticsoral cavity epitheliumpreventprogramsresearch studytumortumor progressiontumorigenic
项目摘要
DESCRIPTION (provided by applicant): The oncogene Ets-1 is over-expressed in a large proportion of oral squamous cell cancers and expression of Ets- 1 is highly-correlated with tumor stage and the presence of lymph node metastases. Ets-1 is known to regulate the expression genes involved in tumor invasion and neo-angiogenesis, including matrix metalloproteases and endothelial cell growth factor receptors. In addition, Ets-1 has been implicated in controlling the expression of genes important for cell cycle progression and for regulating apoptosis. Finally, gene-targeted Ets-1 deficient mice demonstrate a role for Ets-1 in limiting cellular differentiation. Thus, Ets-1 may influence tumor progression in multiple ways by promoting invasion, angiogenesis and proliferation while at the same time limiting apoptosis and preventing terminal differentiation. To better define the precise roles of Ets-1 in oral tumor formation and progression, we have generated a transgenic mouse model system in which expression of Ets-1 can be induced in the differentiated cells of the oral epithelium. Upon Ets-1 induction, these mice exhibit dramatic changes in the epithelium including increased proliferation, blocked terminal differentiation and malignant conversion. We now propose to use this mouse model to identify the mechanisms by which Ets-1 regulates important pathways involved in oral cancer formation. These studies will be supplemented by complementary analyses using cultured oral keratinocytes. The results of our experiments will help to determine whether therapies directed against Ets-1 would be clinically useful in treating aggressive oral squamous cell carcinomas.
Oral squamous cell carcinoma (OSCC) is a neoplasm that arises in the stratified squamous epithelium of the mouth. Five-year survival rates for patients with oral squamous cell cancers have not changed much in the last 20 years, suggesting that new approaches to therapy are needed. Our studies are designed to identify the role of the oncogene Ets-1 in regulating OSCC initiation and progression, with the eventual hope of developing novel strategies to target Ets-1 activity and regulate tumor cell growth.
描述(申请人提供):癌基因Ets-1在大部分口腔鳞状细胞癌中过度表达,并且Ets-1的表达与肿瘤分期和淋巴结转移的存在高度相关。已知 Ets-1 可以调节参与肿瘤侵袭和新血管生成的表达基因,包括基质金属蛋白酶和内皮细胞生长因子受体。此外,Ets-1 还参与控制对细胞周期进程和调节细胞凋亡重要的基因的表达。最后,基因靶向 Ets-1 缺陷小鼠证明了 Ets-1 在限制细胞分化中的作用。因此,Ets-1可能通过促进侵袭、血管生成和增殖,同时限制细胞凋亡和防止终末分化,以多种方式影响肿瘤进展。为了更好地确定 Ets-1 在口腔肿瘤形成和进展中的精确作用,我们构建了转基因小鼠模型系统,其中可以在口腔上皮的分化细胞中诱导 Ets-1 的表达。在 Ets-1 诱导后,这些小鼠表现出上皮细胞的巨大变化,包括增殖增加、终末分化受阻和恶性转化。我们现在建议使用该小鼠模型来确定 Ets-1 调节口腔癌形成重要途径的机制。这些研究将通过使用培养的口腔角质形成细胞的补充分析来补充。我们的实验结果将有助于确定针对 Ets-1 的疗法是否在临床上可用于治疗侵袭性口腔鳞状细胞癌。
口腔鳞状细胞癌(OSCC)是一种产生于口腔复层鳞状上皮的肿瘤。口腔鳞状细胞癌患者的五年生存率在过去 20 年中没有太大变化,这表明需要新的治疗方法。我们的研究旨在确定癌基因 Ets-1 在调节 OSCC 发生和进展中的作用,最终希望开发出针对 Ets-1 活性和调节肿瘤细胞生长的新策略。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Isolation and characterization of an immortalized oral keratinocyte cell line of mouse origin.
长老的口服角质形成细胞系的分离和表征小鼠起源。
- DOI:10.1016/j.archoralbio.2008.07.002
- 发表时间:2008-11
- 期刊:
- 影响因子:3
- 作者:Parikh, Neha;Nagarajan, Priyadharsini;Sei-Ichi, Matsui;Sinha, Satrajit;Garrett-Sinha, Lee Ann
- 通讯作者:Garrett-Sinha, Lee Ann
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LEE ANN Garrett-Sinha其他文献
LEE ANN Garrett-Sinha的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LEE ANN Garrett-Sinha', 18)}}的其他基金
Exploring Roles for Transcription Factor Ets1 in Sjogren's Syndrome
探索转录因子 Ets1 在干燥综合征中的作用
- 批准号:
10644080 - 财政年份:2023
- 资助金额:
$ 3.92万 - 项目类别:
Regulation and Consequences of Ets1 Downregulation in B Cells
B 细胞中 Ets1 下调的调控和后果
- 批准号:
9896768 - 财政年份:2016
- 资助金额:
$ 3.92万 - 项目类别:
Identification of Specific Roles for Ets-1 in B Cell Tolerance
鉴定 Ets-1 在 B 细胞耐受中的具体作用
- 批准号:
8259852 - 财政年份:2010
- 资助金额:
$ 3.92万 - 项目类别:
Identification of Specific Roles for Ets-1 in B Cell Tolerance
鉴定 Ets-1 在 B 细胞耐受中的具体作用
- 批准号:
8070010 - 财政年份:2010
- 资助金额:
$ 3.92万 - 项目类别:
Identification of Specific Roles for Ets-1 in B Cell Tolerance
鉴定 Ets-1 在 B 细胞耐受中的具体作用
- 批准号:
8651860 - 财政年份:2010
- 资助金额:
$ 3.92万 - 项目类别:
Identification of Specific Roles for Ets-1 in B Cell Tolerance
鉴定 Ets-1 在 B 细胞耐受中的具体作用
- 批准号:
8461248 - 财政年份:2010
- 资助金额:
$ 3.92万 - 项目类别:
Identification of Specific Roles for Ets-1 in B Cell Tolerance
鉴定 Ets-1 在 B 细胞耐受中的具体作用
- 批准号:
8516184 - 财政年份:2010
- 资助金额:
$ 3.92万 - 项目类别:
Identification of Specific Roles for Ets-1 in B Cell Tolerance
鉴定 Ets-1 在 B 细胞耐受中的具体作用
- 批准号:
7984141 - 财政年份:2010
- 资助金额:
$ 3.92万 - 项目类别:
Identification of Specific Roles for Ets-1 in B Cell Tolerance
鉴定 Ets-1 在 B 细胞耐受中的具体作用
- 批准号:
8264121 - 财政年份:2010
- 资助金额:
$ 3.92万 - 项目类别:
Ets-1 Expression in Squamous Cells of the Oral Cavity
口腔鳞状细胞中 Ets-1 的表达
- 批准号:
7257725 - 财政年份:2007
- 资助金额:
$ 3.92万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
- 批准号:
10719415 - 财政年份:2023
- 资助金额:
$ 3.92万 - 项目类别:
Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
- 批准号:
10585802 - 财政年份:2023
- 资助金额:
$ 3.92万 - 项目类别:
Interrogating the Fgl2-FcγRIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
询问 CD8 T 细胞上的 Fgl2-FcγRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10605856 - 财政年份:2023
- 资助金额:
$ 3.92万 - 项目类别:
Mechanistic analysis of apoptosis induction by HDAC inhibitors in head and neck cancer
HDAC抑制剂诱导头颈癌凋亡的机制分析
- 批准号:
23K15866 - 财政年份:2023
- 资助金额:
$ 3.92万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Novel targeted therapy for FGFR inhibitor-resistant urothelial cancer and apoptosis based therapy for urothelial cancer
FGFR抑制剂耐药性尿路上皮癌的新型靶向治疗和基于细胞凋亡的尿路上皮癌治疗
- 批准号:
23K08773 - 财政年份:2023
- 资助金额:
$ 3.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
探究 Fgl2-FcgRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10743485 - 财政年份:2023
- 资助金额:
$ 3.92万 - 项目类别:
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
研究细胞凋亡抗性和肿瘤环境对骶尾部畸胎瘤发生和维持的作用
- 批准号:
10749797 - 财政年份:2023
- 资助金额:
$ 3.92万 - 项目类别:
The effects of glucose on immune cell apoptosis and mitochondrial membrane potential and the analysis of its mechanism by which glucose might modulate the immune functions.
葡萄糖对免疫细胞凋亡和线粒体膜电位的影响及其调节免疫功能的机制分析。
- 批准号:
22K09076 - 财政年份:2022
- 资助金额:
$ 3.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
- 批准号:
10583516 - 财政年份:2022
- 资助金额:
$ 3.92万 - 项目类别:
Role of Thioredoxin system in regulation of autophagy-apoptosis cross talk in neurons: Uncovering Novel Molecular Interactions.
硫氧还蛋白系统在神经元自噬-凋亡串扰调节中的作用:揭示新的分子相互作用。
- 批准号:
RGPIN-2019-05371 - 财政年份:2022
- 资助金额:
$ 3.92万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




